Showing results (201-210 of 209) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
Oncotarget|December 31, 2015
Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinomaPi-Lin Sung, Yi-Hua Jan, Shih-Chieh Lin, et al.
Anticancer Research|March 14, 2013
An evaluation of focal adhesion kinase in breast cancer by tissue microarraysShyr-Ming Sheen-Chen, Chun-Ying Huang, Yi-Chia Chan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 3, 2014
A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infectionKuo-Chin Chang, Po-Lin Tseng, Yi-Ying Wu, et al.
The Journal of Biological Chemistry|September 2, 2022
Leukocyte cell-derived chemotaxin 2 regulates epithelial-mesenchymal transition and cancer stemness in hepatocellular carcinomaTian-Huei Chu, Chou-Yuan Ko, Po-Han Tai, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 16, 2020
Hepatoma-derived growth factor participates in concanavalin A-induced hepatitisE-Ming Wang, Tsung-Hui Hu, Chao-Cheng Huang, et al.
Genes|April 23, 2022
DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics AnalysisMan-Gang Lee, Yung-Kuo Lee, Shih-Chung Huang, et al.
Toxicology and Applied Pharmacology|August 14, 2025
Empagliflozin attenuates sorafenib-promoted renal ferroptosis and inflammation by targeting cyclooxygenase-2/prostaglandin E2 axisMing-Kai Tsai, Wen-Chin Lee, Shih-Chung Huang, et al.
Gene|March 5, 2023
Slow skeletal muscle troponin T acts as a potential prognostic biomarker and therapeutic target for hepatocellular carcinomaShih-Chung Huang, Chao-Cheng Huang, Chou-Yuan Ko, et al.
Pathology|November 1, 2022
The Ring Study: an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancerSung-Liang Yu, Yi-Jing Hsiao, Wendy A Cooper, et al.
Pageof 21